perfluorobutane has been researched along with Carcinoma, Hepatocellular in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (12.61) | 29.6817 |
2010's | 70 (63.06) | 24.3611 |
2020's | 27 (24.32) | 2.80 |
Authors | Studies |
---|---|
Cheng, W; Feng, D; Han, X; Li, L; Li, X; Su, C; Sun, J; Zhan, C | 1 |
Cao, JY; Dong, Y; Qiu, YJ; Wang, HZ; Wang, WP; Yu, LY; Zuo, D | 1 |
Luo, B; Tian, J; Wu, J; Xie, W; Xu, X; Zheng, Z | 1 |
Huang, Z; Li, KY; Xin, JY; Zhu, RH | 1 |
Li, C; Liu, Y; Song, J; Wu, M; Xu, J | 1 |
Cheng, Z; Ding, H; Dong, X; Dou, J; Han, Z; Jing, X; Li, K; Li, Y; Liang, P; Liu, F; Lu, S; Luo, Y; Qi, E; Tan, S; Wang, S; Wu, W; Xie, X; Yang, H; Yao, J; Yu, J; Yu, X; Zhang, Y | 1 |
Bae, JS; Cho, YS; Choi, SH; Chung, YE; Hwang, JA; Jeong, WK; Joo, I; Kang, HJ; Kim, B; Kim, DH; Kim, JH; Kim, SY; Lee, JM; Lee, JY; Lee, MW; Lim, S; Park, MS; You, MW; Yu, MH | 1 |
Cheng, W; Cheng, Z; Ding, H; Dou, J; Han, Z; He, G; Jiang, T; Jing, X; Li, K; Li, X; Li, Y; Liang, P; Liu, F; Lu, S; Qi, E; Tan, S; Wang, S; Wu, W; Yan, Y; Yang, H; Yao, J; Yu, J; Yu, X; Zhang, Y | 1 |
Huang, Z; Li, K; Luo, HC; Wu, LL; Xin, JY | 1 |
Chen, S; Dong, Y; Huang, YL; Lu, XY; Qiu, YJ; Wang, WP; Zhang, Q | 1 |
Chen, Y; Cui, R; Liu, G; Qin, S; Wang, Y; Zhou, J | 1 |
Han, H; Jeong, DY; Kang, TW; Lee, MW; Lim, HK; Min, JH; Rhim, H; Sinn, DH; Song, KD | 1 |
Chuma, M; Inayama, Y; Maeda, S; Miwa, H; Moriya, S; Numata, K; Ogushi, K; Okada, M; Otani, M; Wang, F | 1 |
Han, K; Jeong, WK; Lee, JY; Lee, KH; Lee, SJ; Nam, CM; Park, JH; Park, MJ; Park, MS; Park, SH | 1 |
Isomoto, H; Koda, M; Matono, T; Miyoshi, K; Okamoto, T; Sugihara, T | 1 |
Ariizumi, S; Katagiri, S; Murata, K; Nakano, M; Saito, A; Yamamoto, M | 1 |
Chuma, M; Duisyenbi, Z; Fukuda, H; Kondo, M; Maeda, S; Nihonmatsu, H; Nozaki, A; Numata, K; Tanaka, K | 1 |
Fukuda, K; Igura, T; Imai, Y; Kogita, S; Makino, Y; Murakami, T; Ohama, H; Ohashi, H; Sawai, Y; Takamura, M | 1 |
Arizumi, T; Hagiwara, S; Hatanaka, K; Inoue, T; Kitai, S; Kudo, M; Minami, Y; Nishida, N; Sakurai, T; Takita, M; Ueshima, K; Yada, N | 1 |
Aizawa, N; Enomoto, H; Fujimoto, J; Higashiura, A; Hirota, S; Iijima, H; Ikeda, N; Imanishi, H; Ishii, A; Iwata, K; Iwata, Y; Nishiguchi, S; Saito, M; Sakai, Y; Takashima, T; Tanaka, H; Yoh, K | 1 |
Fukuda, K; Hori, M; Igura, T; Imai, Y; Kogita, S; Makino, Y; Morimoto, O; Murakami, T; Nakashima, O; Ohama, H; Ohsawa, M; Sakamoto, M; Sawai, Y; Seki, Y; Takamura, M | 1 |
Fukuda, H; Ishii, T; Kondo, M; Maeda, S; Miwa, H; Morimoto, M; Moriya, S; Nakano, M; Nozaki, A; Nozawa, A; Numata, K; Okada, M; Takebayashi, S; Tanaka, K | 1 |
Chung, H; Haji, S; Hatanaka, K; Inoue, T; Kudo, M; Minami, Y | 1 |
Choi, SY; Kang, TW; Lee, MW; Lim, HK; Lim, S; Min, JH; Rhim, H; Song, KD | 1 |
Iijima, H; Imai, Y; Izumi, N; Kadoya, M; Kudo, M; Matsui, O | 1 |
Ikeda, K; Inokuchi, R; Jyoko, K; Kawamura, Y; Kokubu, S; Kudo, M; Minami, Y; Nagai, K; Nakanishi, H; Nasu, A; Osaki, Y; Saito, Y; Sano, T; Sunagozaka, H; Uchino, K | 1 |
Abo, T; Arai, J; Hidaka, S; Miyaaki, H; Nagayasu, T; Nanashima, A; Shibata, H; Takagi, K; Taura, N; Tobinaga, S | 1 |
Costa, G; Donadon, M; Torzilli, G | 1 |
Horimoto, M; Kojima, F; Okuda, Y; Ota, M; Suzuki, K | 1 |
Kim, JH; Kim, KW; Kim, SY; Lee, MG; Lee, SJ; Shin, YM; You, MW | 1 |
Higaki, A; Hirooka, M; Hyodo, T; Iijima, H; Imai, Y; Inoue, T; Koda, M; Korenaga, K; Kudo, M; Miyoshi, K; Murakami, T; Numata, K; Ochi, H; Suda, T; Takano, T; Tanaka, H | 1 |
Ishige, N; Motoyoshi, Y; Shinozaki, F; Sugiyama, T; Tomizawa, M; Yamamoto, S | 1 |
Maruyama, H; Sekimoto, T; Yokosuka, O | 1 |
Takuma, Y; Tomokuni, J; Toshikuni, N; Yamamoto, H | 1 |
Igarashi, Y; Ikehara, T; Kikuchi, Y; Kogame, M; Matsukiyo, Y; Shinohara, M; Shiozawa, K; Sumino, Y; Watanabe, M | 1 |
Imai, Y; Moriyasu, F; Sugimoto, K; Yoshiyuki, K | 1 |
Eso, Y; Inuzuka, T; Lee, M; Marusawa, H; Matsumoto, T; Seno, H; Takahashi, K; Takai, A; Takeda, H; Ueda, Y | 1 |
Kim, KW; Kim, PN; Lee, SJ; Shin, YM; Won, HJ | 1 |
Goto, T; Hamanaka, J; Ida, T; Inamori, M; Maeda, S; Morohashi, T; Nishigori, S; Ohara, H; Seki, S | 1 |
Lee, HS | 1 |
Chung, H; Hagiwara, S; Hatanaka, K; Inoue, T; Kitai, S; Kudo, M; Maekawa, K; Minami, Y; Takahashi, S; Tatsumi, C; Ueda, T; Ueshima, K | 1 |
Ishibashi, H; Maruyama, H; Okabe, S; Okugawa, H; Takahashi, M; Yokosuka, O; Yoshikawa, M | 1 |
Luo, W; Morimoto, M; Nagano, Y; Nozaki, A; Numata, K; Sugimori, K; Tanaka, K; Zhou, X | 1 |
Hatanaka, K; Kudo, M; Maekawa, K; Minami, Y | 1 |
Chung, H; Hagiwara, S; Hatanaka, K; Inoue, T; Ishikawa, E; Kitai, S; Kudo, M; Maekawa, K; Minami, Y; Takahashi, S; Ueda, T; Ueshima, K | 1 |
Chung, H; Hagiwara, S; Hatanaka, K; Hayaishi, S; Inoue, T; Ishikawa, E; Kitai, S; Kudo, M; Maekawa, K; Minami, Y; Takahashi, S; Tatsumi, C; Ueda, T; Ueshima, K; Xia, Y | 1 |
Kudo, M | 2 |
Luo, W; Morimoto, M; Numata, K; Okada, M; Oshima, T; Takebayashi, S; Tanaka, K; Ueda, M; Zhou, X | 1 |
Furukawa, M; Korenaga, K; Korenaga, M; Sakaida, I; Yamasaki, T | 1 |
Hiramatsu, K; Miyamoto, N; Sato, Y; Shirato, H; Terae, S; Tsuchiya, K | 1 |
Chiba, T; Kita, R; Marusawa, H; Nishijima, N; Osaki, Y | 1 |
Ishibashi, H; Maruyama, H; Okabe, S; Takahashi, M; Yokosuka, O; Yoshikawa, M | 1 |
Fujisawa, T; Hachisuka, Y; Mogami, H; Uomoto, M | 1 |
Fukuda, H; Itou, R; Karasawa, E; Kondou, M; Morimoto, M; Nozaki, A; Numata, K; Ohto, M; Tanaka, K | 1 |
Iida, K; Shiozawa, K; Sumino, Y; Takahashi, M; Takayama, R; Wakui, N; Watanabe, M | 1 |
Chung, H; Hagiwara, S; Hatanaka, K; Inoue, T; Kitai, S; Kudo, M; Minami, Y; Ueshima, K | 1 |
Hiramatsu, K; Miyamoto, N; Sato, Y; Tsuchiya, K | 1 |
Hatanaka, K; Kudo, M; Maekawa, K | 1 |
Chung, H; Hagiwara, S; Haji, S; Hatanaka, K; Hayaishi, S; Inoue, T; Ishikawa, E; Kitai, S; Kudo, K; Kudo, M; Maekawa, K; Minami, Y; Nagai, T; Takita, M; Tatsumi, C; Ueda, T; Ueshima, K; Yada, N | 1 |
Hatanaka, K; Inoue, T; Kudo, M; Maekawa, K | 1 |
Andreana, L; Chung, H; Hatanaka, K; Kudo, M; Maekawa, K; Minami, Y; Ruggiero, G | 1 |
Goto, E; Goto, T; Ikeda, H; Koike, K; Kondo, Y; Masuzaki, R; Omata, M; Shiina, S; Sugioka, Y; Tateishi, R; Yoshida, H | 1 |
Abo, T; Hidaka, S; Ichikawa, T; Kunizaki, M; Nagayasu, T; Nakao, K; Nanashima, A; Sawai, T; Takeshita, H; Taura, N; Tobinaga, S | 1 |
Hatanaka, K; Kudo, M; Kumada, T; Tada, T; Toyoda, H | 1 |
Hiasa, Y; Hiraoka, A; Michitaka, K; Onji, M | 1 |
Arita, J; Hasegawa, K; Hata, S; Kokudo, N; Shindoh, J; Sugawara, Y; Takahashi, M | 1 |
Fukuda, H; Ito, R; Karasawa, E; Ohto, M; Sakamoto, A; Shinozuka, N; Wanga, ZB; Yamaguchi, T; Zhu, H | 1 |
Fukuda, K; Igura, T; Imai, Y; Kogita, S; Murakami, T; Ohama, H; Okada, M; Sawai, Y; Seki, Y; Takamura, M | 1 |
Arita, J; Beck, Y; Hasegawa, K; Hata, S; Kokudo, N; Shindoh, J; Sugawara, Y; Takahashi, M | 1 |
Hirono, S; Kawai, M; Kiriyama, S; Ozawa, S; Shigekawa, Y; Tani, M; Uchiyama, K; Ueno, M; Yamaue, H | 1 |
Kaneko, T; Kunishi, Y; Maeda, S; Morimoto, M; Numata, K; Okada, M; Tanaka, K | 1 |
Akahane, M; Goto, E; Goto, T; Ikeda, H; Imamura, J; Koike, K; Kondo, Y; Masuzaki, R; Omata, M; Shiina, S; Tateishi, R; Yoshida, H | 1 |
Alaboudy, A; Chung, H; Hatanaka, K; Hyodo, T; Inoue, T; Kudo, M; Kumano, S; Moustafa, EF; Murakami, T | 1 |
Anezaki, Y; Dohmen, T; Goto, T; Ishii, H; Kamada, K; Kataoka, E; Miura, K; Ohnishi, H; Ohshima, S; Sato, W; Segawa, D; Shibuya, T; Yamada, I | 1 |
Kamesaki, H; Kanai, F; Maruyama, H; Sekimoto, T; Shimada, T; Takahashi, M; Yokosuka, O | 1 |
Arii, S; Ban, D; Iijima, H; Irie, T; Kudo, A; Mitsunori, Y; Nakamura, N; Noguchi, N; Tanaka, S | 1 |
Imai, Y; Moriyasu, F; Oshiro, H; Saguchi, T; Saito, K; Shiraishi, J; Sugimoto, K; Taira, J; Yoshimura, N | 1 |
Seyama, Y; Shindoh, J; Umekita, N | 1 |
Barr, RG; Chammas, MC; Chaubal, NG; Chen, MH; Choi, BI; Claudon, M; Clevert, DA; Correas, JM; Cosgrove, DO; Dietrich, CF; Ding, H; Forsberg, F; Fowlkes, JB; Gibson, RN; Goldberg, BB; Kudo, M; Lassau, N; Leen, EL; Mattrey, RF; Moriyasu, F; Nolsøe, CP; Piscaglia, F; Solbiati, L; Weskott, HP; Wilson, SR; Xu, HX | 1 |
Kikuchi, Y; Kudo, T; Maruyama, K; Shiozawa, K; Sumino, Y; Watanabe, M | 1 |
Furuichi, Y; Imai, Y; Kamiyama, N; Moriyasu, F; Rognin, N; Saito, K; Sugimoto, K | 1 |
Blomley, MJ; Cosgrove, DO; Gedroyc, WM; Harvey, CJ; Lim, AK; Taylor-Robinson, SD | 1 |
Morimoto, M; Numata, K; Ogura, T; Okada, M; Sugimori, K; Takebayashi, S; Tanaka, K | 1 |
Ge, L; Lu, L; Wu, J | 1 |
Guo, Z; Han, J; Hu, Y; Li, L; Li, X; Wang, J; Zheng, W; Zhou, J | 1 |
King, KG | 1 |
Hwang, JA; Jeong, WK; Kang, HJ; Lee, ES; Lee, JM; Park, HJ | 1 |
Bansal, A; Mukund, A; Patidar, Y; Sarin, SK; Sharma, MK; Thapar, S | 1 |
Swensson, J | 1 |
Bae, JS; Cho, EJ; Han, JK; Hong, SK; Kim, YJ; Lee, JH; Lee, JY; Lee, YB; Suh, KS; Yoon, JH; Yu, SJ | 1 |
Bae, JS; Han, S; Joo, I; Kang, HJ; Kim, SW; Lee, JM; Park, S; Yoo, J; Yoon, JH | 1 |
Guo, Z; Han, J; Li, K; Li, L; Li, Q; Li, Y; Su, Z; Wang, J; Wen, H; Xie, S; Xu, X; Zheng, W; Zhou, J; Zou, R; Zou, X; Zuo, Y | 1 |
Gogna, A; Irani, FG; Leong, S; Lo, RHG; Ong, YT; Sanamandra, SK; Shi, H; Too, CW; Venkatanarasimha, N | 1 |
Han, JK; Kang, HJ; Kim, H; Lee, JM; Lee, K; Yoon, JH | 1 |
Jang, HJ; Kim, TK | 1 |
Liu, C; Liu, K; Yan, J; Yang, Y | 1 |
Iwamoto, H; Kamachi, N; Koga, H; Kuromatsu, R; Nakano, M; Niizeki, T; Noda, Y; Okamura, S; Shimose, S; Shirono, T; Torimura, T | 1 |
Deguchi, H; Fukatsu, K; Hayami, S; Ida, Y; Iguchi, M; Itonaga, M; Kato, J; Maeda, Y; Maekita, T; Moribata, K; Nuta, J; Shimizu, R; Shingaki, N; Tamai, H; Ueno, M; Yamaue, H; Yoshida, T | 1 |
Han, K; Jeong, WK; Lee, JY; Lee, KH; Lee, SJ; Lee, SS; Nam, CM; Park, JH; Park, MJ; Park, MS; Park, SH | 1 |
Ito, T; Kaneoka, Y; Kumada, T; Maeda, A; Okuda, S; Otobe, K; Sone, Y; Tada, T; Takahashi, K; Toyoda, H | 2 |
Chuma, M; Fukuda, H; Inayama, Y; Kondo, M; Maeda, S; Morimoto, M; Murakami, T; Nakano, M; Nihonmatsu, H; Nozaki, A; Numata, K; Okada, M; Oshima, T; Takebayashi, S; Tanaka, K | 1 |
Chiba, T; Kanai, F; Kiyono, S; Kondo, T; Maruyama, H; Ogasawara, S; Ooka, Y; Sekimoto, T; Shimada, T; Suzuki, E; Takahashi, M; Tawada, A; Yokosuka, O | 1 |
Deguchi, H; Ichinose, M; Iguchi, M; Inoue, I; Kato, J; Maeda, Y; Maekita, T; Maeshima, S; Mori, Y; Moribata, K; Niwa, T; Nuta, J; Shimizu, R; Shingaki, N; Tamai, H | 1 |
Deguchi, H; Ichinose, M; Iguchi, M; Inoue, I; Kato, J; Maeda, Y; Maekita, T; Maeshima, S; Mori, Y; Moribata, K; Niwa, T; Nuta, J; Shagdarsuren, B; Shingaki, N; Tamai, H | 1 |
Koda, M; Mandai, M; Matono, T; Murawaki, Y; Nagahara, T; Ohyama, K; Sugihara, T; Ueki, M | 1 |
Ishibashi, H; Maruyama, H; Takahashi, M; Yokosuka, O; Yoshikawa, M | 2 |
Fukuda, H; Kondo, M; Maeda, S; Morimoto, M; Nozaki, A; Numata, K; Okada, M; Oshima, T; Takebayashi, S; Tanaka, K | 1 |
Kamezaki, H; Kanai, F; Maruyama, H; Sekimoto, T; Shimada, T; Takahashi, M; Yokosuka, O | 1 |
10 review(s) available for perfluorobutane and Carcinoma, Hepatocellular
Article | Year |
---|---|
Utility of Sonazoid-Enhanced Ultrasound for the Macroscopic Classification of Hepatocellular Carcinoma: A Meta-analysis.
Topics: Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Oxides; Sensitivity and Specificity | 2022 |
Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Radiology; Republic of Korea; Ultrasonography | 2023 |
Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
Topics: Algorithms; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Early Detection of Cancer; Ferric Compounds; Gadolinium DTPA; Health Care Surveys; Humans; Iron; Japan; Liver Neoplasms; Magnetic Resonance Imaging; Mass Screening; Oxides; Population Surveillance; Practice Patterns, Physicians'; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Ferric Compounds; Humans; Iron; Japan; Liver Neoplasms; Magnetic Resonance Imaging; Microwaves; Oxides; Temperature; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Interventional | 2014 |
State of the art of intraoperative ultrasound in liver surgery: current use for staging and resection guidance.
Topics: Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast Media; Ferric Compounds; Hepatectomy; Humans; Intraoperative Complications; Iron; Liver; Liver Failure; Liver Neoplasms; Neoplasm Staging; Oxides; Phospholipids; Sensitivity and Specificity; Sulfur Hexafluoride; Ultrasonography, Interventional | 2014 |
Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.
Topics: Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Humans; Iron; Liver Neoplasms; Oxides; Prognosis; Quality of Life; Ultrasonography | 2016 |
Multistep human hepatocarcinogenesis: correlation of imaging with pathology.
Topics: Angiography; Carcinoma, Hepatocellular; Disease Progression; Ferric Compounds; Gadolinium DTPA; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Oxides; Portography; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Contrast-enhanced ultrasound techniques for guiding and assessing response to locoregional treatments for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Humans; Iron; Liver Neoplasms; Oxides; Treatment Outcome; Ultrasonography | 2010 |
Diagnostic imaging of hepatocellular carcinoma: recent progress.
Topics: Angiography; Carcinoma, Hepatocellular; Diagnostic Imaging; Ferric Compounds; Gadolinium DTPA; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Oxides; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2011 |
Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis.
Topics: Carcinoma, Hepatocellular; Contrast Media; Fluorocarbons; Humans; Liver Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2021 |
5 trial(s) available for perfluorobutane and Carcinoma, Hepatocellular
Article | Year |
---|---|
Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Cross-Sectional Studies; Early Detection of Cancer; Female; Ferric Compounds; Humans; Image Interpretation, Computer-Assisted; Iron; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Oxides; Research Design; Ultrasonography; Young Adult | 2017 |
The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Middle Aged; Multidetector Computed Tomography; Oxides; Prospective Studies; Reproducibility of Results; Ultrasonography | 2014 |
Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Ferric Compounds; Hepatectomy; Humans; Imaging, Three-Dimensional; Iron; Liver Neoplasms; Male; Middle Aged; Oxides; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Ultrasonography | 2010 |
Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Gadolinium DTPA; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Oxides; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2012 |
Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Fluorocarbons; Humans; Iopamidol; Liver Neoplasms; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2012 |
96 other study(ies) available for perfluorobutane and Carcinoma, Hepatocellular
Article | Year |
---|---|
Dynamic Contrast-Enhanced Ultrasonography with Sonazoid for Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Ferric Compounds; Humans; Iron; Liver Neoplasms; Neoplasm Invasiveness; Oxides; Retrospective Studies; Ultrasonography | 2022 |
Preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma based on kupffer phase radiomics features of sonazoid contrast-enhanced ultrasound (SCEUS): A prospective study.
Topics: Carcinoma, Hepatocellular; Ferric Compounds; Humans; Iron; Liver Neoplasms; Neoplasm Invasiveness; Oxides; Prospective Studies; Retrospective Studies | 2022 |
HCC treated with immune checkpoint inhibitors: a hyper-enhanced rim on Sonazoid-CEUS Kupffer phase images is a predictor of tumor response.
Topics: B7-H1 Antigen; Carcinoma, Hepatocellular; Contrast Media; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Retrospective Studies | 2023 |
Role of Sonazoid enhanced ultrasound assistant laparoscopic radiofrequency ablation in treating liver malignancy-A single-center retrospective cohort study.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Humans; Laparoscopy; Liver Neoplasms; Radiofrequency Ablation; Retrospective Studies; Ultrasonography | 2023 |
Analysis of Sonazoid contrast-enhanced ultrasound for predicting the risk of microvascular invasion in hepatocellular carcinoma: a prospective multicenter study.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Neoplasm Invasiveness; Prospective Studies; Retrospective Studies; Risk Factors | 2023 |
Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Humans; Liver Neoplasms; Nomograms; Prospective Studies; Retrospective Studies | 2023 |
Dynamic contrast-enhanced ultrasonography with sonazoid predicts microvascular invasion in early-stage hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Neoplasm Invasiveness; Prospective Studies; Retrospective Studies; Ultrasonography | 2023 |
Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Retrospective Studies; Ultrasonography | 2024 |
Percutaneous ablation of colorectal liver metastases: a comparison between the outcomes of grayscale US guidance and Sonazoid CEUS Kupffer phase guidance using propensity score matching.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Humans; Liver Neoplasms; Propensity Score; Retrospective Studies; Treatment Outcome | 2023 |
Effect of Perfluorobutane Microbubbles on Radiofrequency Ablation for Hepatocellular Carcinoma: Suppression of Steam Popping and Its Clinical Implication.
Topics: Aged; Carcinoma, Hepatocellular; Case-Control Studies; Disease Progression; Disease-Free Survival; Female; Ferric Compounds; Fluorocarbons; Humans; Iron; Liver Neoplasms; Male; Microbubbles; Middle Aged; Oxides; Radiofrequency Ablation; Retrospective Studies; Treatment Outcome; Ultrasonography | 2020 |
A study on the inconsistency of arterial phase hypervascularity detection between contrast-enhanced ultrasound using sonazoid and gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid magnetic resonance imaging of hepatocellular carcinoma lesions.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Gadolinium DTPA; Humans; Image Enhancement; Iron; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Oxides; Reproducibility of Results; Retrospective Studies; Ultrasonography | 2021 |
Two patterns of contrast-enhanced ultrasonography with Sonazoid
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Embolization, Therapeutic; Ferric Compounds; Hemorrhage; Hepatic Artery; Humans; Iron; Liver; Liver Neoplasms; Male; Middle Aged; Oxides; Rupture, Spontaneous; Ultrasonography | 2018 |
Association of des-γ-carboxy prothrombin production and Sonazoid-enhanced ultrasound findings in hepatocellular carcinomas of different histologic grades.
Topics: Adult; Aged; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Immunohistochemistry; Iron; Liver Neoplasms; Middle Aged; Oxides; Protein Precursors; Prothrombin; Single-Blind Method | 2018 |
Comparison Between Low Mechanical Index and High Mechanical Index Contrast Modes of Contrast-Enhanced Ultrasonography: Evaluation of Perfusion Defects of Hypervascular Hepatocellular Carcinomas During the Post-Vascular Phase.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Iron; Liver; Liver Neoplasms; Male; Middle Aged; Oxides; Ultrasonography | 2019 |
Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chi-Square Distribution; Contrast Media; Ferric Compounds; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Oxides; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2013 |
Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Ferric Compounds; Humans; Iron; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oxides; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2013 |
New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Iron; Kupffer Cells; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Oxides; Portal Vein; Retrospective Studies; Single-Blind Method; Ultrasonography | 2014 |
Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Gadolinium DTPA; Humans; Image Enhancement; Immunohistochemistry; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Oxides; Retrospective Studies; Ultrasonography | 2014 |
Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Early Detection of Cancer; Female; Ferric Compounds; Gadolinium DTPA; Humans; Image Enhancement; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Oxides; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oxides; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; False Negative Reactions; False Positive Reactions; Feasibility Studies; Female; Ferric Compounds; Fluorescent Dyes; Gallbladder Neoplasms; Hepatectomy; Humans; Indocyanine Green; Intraoperative Care; Iron; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Oxides; Ultrasonography | 2015 |
Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; End Stage Liver Disease; Female; Ferric Compounds; Hepatic Artery; Humans; Image Enhancement; Iron; Kupffer Cells; Liver Neoplasms; Male; Middle Aged; Oxides; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2015 |
Recent advances in the imaging of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Oxides; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Female; Ferric Compounds; Gadolinium DTPA; Humans; Iron; Kaplan-Meier Estimate; Kupffer Cells; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Oxides; Retrospective Studies; Ultrasonography | 2016 |
Suppression of hepatocellular carcinoma cell proliferation by short hairpin RNA of frizzled 2 with Sonazoid-enhanced irradiation.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Ferric Compounds; Frizzled Receptors; Gene Expression Regulation, Neoplastic; Humans; Iron; Liver Neoplasms; Matrix Metalloproteinase 9; Oxides; Radiation Tolerance; RNA, Small Interfering; Ultrasonic Waves | 2016 |
Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Ferric Compounds; Humans; Image Interpretation, Computer-Assisted; Iron; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oxides; Predictive Value of Tests; Radiography, Interventional; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Ultrasonography | 2015 |
[Evaluation of Sorafenib for Hepatocellular Carcinoma with Low α-Fetoprotein by Arrival Time Parametric Imaging Using Contrast-Enhanced Ultrasonography with Sonazoid].
Topics: Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Middle Aged; Niacinamide; Oxides; Phenylurea Compounds; Sorafenib; Time Factors; Ultrasonography | 2016 |
Assessment of irreversible electroporation ablation zone using Kupffer-phase contrast-enhanced ultrasound images with Sonazoid.
Topics: Ablation Techniques; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Electroporation; Ferric Compounds; Gadolinium DTPA; Hepatitis C; Humans; Iron; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Oxides; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2014 |
Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Biopsy, Needle; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Ferric Compounds; Focal Nodular Hyperplasia; Humans; Image-Guided Biopsy; Iron; Liver; Liver Abscess; Liver Neoplasms; Male; Middle Aged; Oxides; Retrospective Studies; Ultrasonography | 2016 |
Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Liver; Liver Neoplasms; Male; Middle Aged; Oxides; Preoperative Care; Prospective Studies; Ultrasonography | 2017 |
Evaluation of local tumor residue after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Middle Aged; Neoplasm, Residual; Oxides; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2017 |
New diagnostic tools of hepatitis virus-related liver diseases. Preface.
Topics: Antiviral Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Diagnosis, Differential; Drug Resistance, Viral; Elasticity Imaging Techniques; Ferric Compounds; Hepatitis B virus; Hepatitis, Viral, Human; Humans; Iron; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Oxides; Tomography, X-Ray Computed | 2008 |
Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Diagnosis, Differential; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Kupffer Cells; Liver; Liver Neoplasms; Male; Middle Aged; Oxides; Sensitivity and Specificity; Ultrasonography | 2008 |
Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Ferric Compounds; Humans; Iron; Liver Neoplasms; Oxides; Ultrasonography | 2009 |
Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Iron; Liver Neoplasms; Male; Oxides; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2009 |
Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Oxides; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Dextrans; Female; Ferric Compounds; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Retrospective Studies; Ultrasonography | 2008 |
Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Epirubicin; Female; Ferric Compounds; Humans; Iodized Oil; Iron; Liver Neoplasms; Male; Middle Aged; Oxides; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Oxides; Ultrasonography | 2009 |
Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Chi-Square Distribution; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Liver Neoplasms; Male; Middle Aged; Oxides; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Education and Imaging. Hepatobiliary and pancreatic: spontaneous regression of hepatocellular cancer demonstrated by contrast-enhanced ultrasonography.
Topics: Aged, 80 and over; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Oxides; Remission, Spontaneous; Ultrasonography | 2009 |
Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Metabolic Clearance Rate; Microbubbles; Middle Aged; Neovascularization, Pathologic; Oxides; Radiographic Image Enhancement; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2010 |
[First reported case of lung metastasis from hepatocellular carcinoma successfully treated by ultrasound-guided radiofrequency ablation using ultrasonic contrast agent].
Topics: Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Ferric Compounds; Humans; Iron; Liver Neoplasms; Lung Neoplasms; Male; Oxides; Ultrasonography | 2009 |
Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Fluorocarbons; High-Intensity Focused Ultrasound Ablation; Humans; Imaging, Three-Dimensional; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Oxides; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2010 |
Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Oxides; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Microbubbles; Middle Aged; Oxides; Phospholipids; Sulfur Hexafluoride; Ultrasonography | 2010 |
Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Ferric Compounds; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Iron; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oxides; Treatment Outcome; Ultrasonography | 2010 |
Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Ferric Compounds; Humans; Iron; Liver Neoplasms; Oxides; Sensitivity and Specificity; Ultrasonography | 2010 |
Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Middle Aged; Oxides; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2010 |
Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnostic Imaging; Ferric Compounds; Hepatic Artery; Humans; Iron; Liver Circulation; Liver Neoplasms; Oxides; Portal Vein; Ultrasonography | 2010 |
Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Case-Control Studies; Catheter Ablation; Contrast Media; Female; Ferric Compounds; Humans; Iron; Japan; Kupffer Cells; Liver Neoplasms; Male; Middle Aged; Oxides; Predictive Value of Tests; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Usefulness of sonazoid-ultrasonography during hepatectomy in patients with liver tumors: A preliminary study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Female; Ferric Compounds; Hepatectomy; Humans; Iron; Liver Neoplasms; Male; Middle Aged; Monitoring, Intraoperative; Oxides; Surgery, Computer-Assisted; Ultrasonography | 2011 |
Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Humans; Iron; Japan; Liver Neoplasms; Neoplasm Staging; Oxides; Practice Guidelines as Topic; Sensitivity and Specificity; Ultrasonography | 2011 |
New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Ferric Compounds; Humans; Iron; Kupffer Cells; Liver Neoplasms; Oxides; Predictive Value of Tests; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Intraoperative Period; Iron; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Oxides; Prospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Treatment of small hepatocellular carcinomas with US-guided high-intensity focused ultrasound.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Gadolinium DTPA; High-Intensity Focused Ultrasound Ablation; Humans; Iron; Liver Function Tests; Liver Neoplasms; Magnetic Resonance Imaging; Male; Oxides; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Interventional | 2011 |
[Advances in imaging modalities of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnostic Imaging; Ferric Compounds; Gadolinium DTPA; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Multidetector Computed Tomography; Oxides | 2011 |
Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contrast Media; Diagnosis, Differential; Female; Ferric Compounds; Humans; Intraoperative Period; Iron; Kupffer Cells; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Oxides; Prospective Studies; Sensitivity and Specificity; Ultrasonography; Young Adult | 2011 |
Combined intraoperative use of contrast-enhanced ultrasonography imaging using a sonazoid and fluorescence navigation system with indocyanine green during anatomical hepatectomy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cohort Studies; Contrast Media; Female; Ferric Compounds; Fluorescent Dyes; Follow-Up Studies; Hepatectomy; Humans; Image Enhancement; Indocyanine Green; Intraoperative Care; Iron; Liver Neoplasms; Male; Middle Aged; Oxides; Prospective Studies; Risk Assessment; Surgery, Computer-Assisted; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Oxides; Prospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Liver; Liver Neoplasms; Male; Middle Aged; Oxides; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomograph
Topics: Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Ferric Compounds; Gadolinium DTPA; Hepatitis B; Hepatitis C; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Oxides; Radiographic Image Enhancement; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2011 |
Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oxides; Radiofrequency Therapy; Ultrasonography | 2012 |
Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cell Differentiation; Contrast Media; Diagnosis, Differential; Female; Ferric Compounds; Humans; Iron; Liver Cirrhosis; Liver Neoplasms; Liver Regeneration; Male; Metabolic Clearance Rate; Microbubbles; Middle Aged; Oxides; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Ultrasonography | 2012 |
Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Ferric Compounds; Follow-Up Studies; Hepatectomy; Humans; Intraoperative Period; Iron; Liver Neoplasms; Male; Middle Aged; Oxides; Retrospective Studies; Sensitivity and Specificity; Ultrasonography | 2013 |
Three-dimensional staining of liver segments with an ultrasound contrast agent as an aid to anatomic liver resection.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Hepatectomy; Humans; Imaging, Three-Dimensional; Indigo Carmine; Iron; Liver; Liver Neoplasms; Male; Microbubbles; Oxides; Ultrasonography, Interventional | 2012 |
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
Topics: Anaphylaxis; Biopsy, Needle; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contraindications; Contrast Media; Diagnosis, Differential; Drug Hypersensitivity; Drug Interactions; Ferric Compounds; Fluorocarbons; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Iron; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Liver Transplantation; Oxides; Phospholipids; Risk Factors; Sulfur Hexafluoride; Ultrasonography, Doppler; Ultrasonography, Interventional | 2013 |
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Middle Aged; Niacinamide; Oxides; Phenylurea Compounds; Pilot Projects; Predictive Value of Tests; Protein Kinase Inhibitors; Sorafenib; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2012 |
Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Area Under Curve; Carcinoma, Hepatocellular; Contrast Media; Disease-Free Survival; Female; Ferric Compounds; Humans; Iron; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Oxides; Perfusion Imaging; Phenylurea Compounds; Predictive Value of Tests; Prospective Studies; Protein Kinase Inhibitors; Reproducibility of Results; Sorafenib; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2013 |
Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Humans; Iron; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasms, Unknown Primary; Oxides; Sensitivity and Specificity; Ultrasonography, Interventional | 2002 |
Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.
Topics: Aged; Analysis of Variance; Biopsy; Carcinoma, Hepatocellular; Catheter Ablation; Chi-Square Distribution; Contrast Media; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Male; Middle Aged; Oxides; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Interventional | 2008 |
Letter to the editor on "Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis".
Topics: Carcinoma, Hepatocellular; Fluorocarbons; Humans; Liver Neoplasms; Ultrasonography | 2022 |
Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2022 |
Editorial Comment: Future Incorporation of Kupffer Cell Agents Into Contrast-Enhanced Ultrasound LI-RADS May Increase Sensitivity for HCC Without Compromising Specificity.
Topics: Carcinoma, Hepatocellular; Fluorocarbons; Humans; Kupffer Cells; Liver Neoplasms | 2022 |
Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Retrospective Studies; Sensitivity and Specificity; Ultrasonography | 2022 |
Role of contrast-enhanced ultrasound with Perfluorobutane in lesion detection, guidance for microwave ablation, and response assessment of hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Fluorocarbons; Humans; Liver Neoplasms; Male; Microwaves; Middle Aged; Prospective Studies; Ultrasonography | 2022 |
Editorial Comment: Expanding the Contrast-Enhanced Ultrasound Toolbox With Perfluorobutane Microbubble Contrast Agents.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Microbubbles; Tomography, X-Ray Computed; Ultrasonography | 2023 |
Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Prospective Studies | 2023 |
Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Ultrasonography | 2023 |
Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Sulfur Hexafluoride | 2023 |
Perfluorobutane contrast-enhanced ultrasonography: a new standard for ultrasonography-guided thermal ablation of sonographically occult liver tumours?
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Fluorocarbons; Humans; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Ultrasonography | 2021 |
Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Sulfur Hexafluoride | 2020 |
Emerging Evidence of the Utility of Perfluorobutane-enhanced US as a Diagnostic Test for Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Diagnostic Tests, Routine; Fluorocarbons; Humans; Liver Neoplasms; Sulfur Hexafluoride; Ultrasonography | 2020 |
Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast-enhanced ultrasound.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Liver Neoplasms; Male; Phenylurea Compounds; Prospective Studies; Protein Kinase Inhibitors; Quinolines; Ultrasonography | 2022 |
Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Liver; Liver Neoplasms; Male; Microbubbles; Middle Aged; Neoplasms, Second Primary; Retrospective Studies; Ultrasonography | 2017 |
Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Liver; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Ultrasonography | 2019 |
Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorocarbons; Follow-Up Studies; Hepatectomy; Humans; Image Enhancement; Liver; Liver Neoplasms; Male; Retrospective Studies; ROC Curve; Ultrasonography | 2014 |
Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic live
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chronic Disease; Contrast Media; Diagnosis, Differential; Female; Fluorocarbons; Humans; Image Enhancement; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Ultrasonography | 2015 |
Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Liver; Liver Neoplasms; Male; Neoplasm Grading; Reproducibility of Results; ROC Curve; Ultrasonography | 2015 |
Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Cell Differentiation; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Liver; Liver Neoplasms; Male; Microbubbles; Prospective Studies; Reproducibility of Results; Ultrasonography | 2015 |
Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
Topics: Ablation Techniques; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Kupffer Cells; Liver Neoplasms; Male; Microbubbles; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome | 2016 |
Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Liver Neoplasms; Male; Microbubbles; Middle Aged; Neoplasm Recurrence, Local; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2016 |
Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Kupffer Cells; Liver Neoplasms; Male; Microbubbles; Neoplasm Recurrence, Local; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chronic Disease; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Cell Differentiation; Contrast Media; Female; Fluorocarbons; Hepatic Artery; Humans; Image Enhancement; Liver Neoplasms; Male; Microbubbles; Middle Aged; Predictive Value of Tests; Prospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Early Detection of Cancer; Female; Fluorocarbons; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2013 |